Subsequent Events	3 Months Ended
Mar. 31, 2018
Notes to Financial Statements
Note 7. Subsequent Events	The Company has evaluated events from March 31, 2018, through the date whereupon the financial statements were issued and has determined that the items below need to be disclosed. The Company issued 21,740 shares of common stock for proceeds of $15,000 and issued 800,000 shares of common stock to various individuals for services related to the medical advisory board. The Company by board resolution approved an executive compensation stock bonus package for Mr. Beplate such that upon the sale of all or substantially all of the assets of the Company or other change in control or merger transaction in which the Company is involved, or in the event that no such transaction occurs by December 31, 2019, Mr. Beplate shall receive an amount equal to 15% post issuance of the then outstanding shares of the Company's common stock on a fully diluted basis. It is intended that the board approved stock bonus package will be in lieu of the 5% stock bonus that Mr. Beplate is already entitled to in the event of a sale of the Company’s assets or change in control or merger transaction per his employment agreement.

Subsequent Events

3 Months Ended

Mar. 31, 2018

The Company has evaluated events from March 31, 2018, through the date whereupon the financial statements were issued and has determined that the items below need to be disclosed.

The Company issued 21,740 shares of common stock for proceeds of $15,000 and issued 800,000 shares of common stock to various individuals for services related to the medical advisory board.

The Company by board resolution approved an executive compensation stock bonus package for Mr. Beplate such that upon the sale of all or substantially all of the assets of the Company or other change in control or merger transaction in which the Company is involved, or in the event that no such transaction occurs by December 31, 2019, Mr. Beplate shall receive an amount equal to 15% post issuance of the then outstanding shares of the Company's common stock on a fully diluted basis. It is intended that the board approved stock bonus package will be in lieu of the 5% stock bonus that Mr. Beplate is already entitled to in the event of a sale of the Company’s assets or change in control or merger transaction per his employment agreement.